Testing version — LOERadar is in active testing. Features and data may change.

POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (POTASSIUM CHLORIDE; SODIUM CHLORIDE) | LOERadar

Viewing data from:

POTASSIUM CHLORIDE 0.037% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

NDA

POTASSIUM CHLORIDE; SODIUM CHLORIDE | N019708 | B BRAUN MEDICAL INC

6 strengths0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

Approval Letters

3 letters from Drugs@FDA

Date	Submission	Document
Jan 22, 2026	SUPPL -40	View Letter (PDF)
Sep 8, 2005	SUPPL -16	View Letter (PDF)
Sep 29, 2004	SUPPL -13	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (6)

Sort:

#001 — 37MG/100ML;900MG/100ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Sep 29, 1989

No patent or exclusivity listings for this strength.

#002 — 75MG/100ML;900MG/100ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Sep 29, 1989

#003 — 110MG/100ML;900MG/100ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Sep 29, 1989

#004 — 150MG/100ML;900MG/100ML

AP

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Sep 29, 1989

#005 — 220MG/100ML;900MG/100ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Sep 29, 1989

#006 — 300MG/100ML;900MG/100ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Sep 29, 1989